Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

AVITA Medical (RCEL) Current Assets (2018 - 2025)

AVITA Medical (RCEL) has disclosed Current Assets for 4 consecutive years, with $35.5 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Current Assets fell 37.74% year-over-year to $35.5 million, compared with a TTM value of $35.5 million through Dec 2025, down 37.74%, and an annual FY2025 reading of $35.5 million, down 37.74% over the prior year.
  • Current Assets was $35.5 million for Q4 2025 at AVITA Medical, down from $41.4 million in the prior quarter.
  • Across five years, Current Assets topped out at $104.0 million in Q4 2023 and bottomed at $35.5 million in Q4 2025.
  • Average Current Assets over 4 years is $71.3 million, with a median of $75.7 million recorded in 2023.
  • The sharpest move saw Current Assets rose 18.92% in 2023, then crashed 50.31% in 2025.
  • Year by year, Current Assets stood at $87.5 million in 2022, then grew by 18.92% to $104.0 million in 2023, then plummeted by 45.2% to $57.0 million in 2024, then plummeted by 37.74% to $35.5 million in 2025.
  • Business Quant data shows Current Assets for RCEL at $35.5 million in Q4 2025, $41.4 million in Q3 2025, and $36.3 million in Q2 2025.